Development of a microfluidic platform to study microRNA levels in clinical material utilizing single cell analysis
Vanessa Ho a, David Klug a, Louise Donnelly b, Peter Barnes b, Keith Willison a, Jonathan Baker b
a Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, Shepherd’s Bush, London, W12 0BZ, UK
b National Heart and Lung Institute, Imperial College London, Dovehouse Street, London, United Kingdom
Proceedings of Emerging Investigators in Microfluidics Conference (EIMC)
Online, Spain, 2021 July 20th - October 6th
Organizers: Adrian Nightingale, Darius Rackus and Claire Stanley
Poster, Vanessa Ho, 006
Publication date: 5th July 2021
ePoster: 

MicroRNAs (miRNA) are a class of short non-coding RNAs (22 nucleotides) that are post-transcriptional regulators. Conventional miRNA detection methods such as northern blotting, next-generation sequencing, and the gold standard, real-time qPCR rely on bulk cell analysis. These methods often also require large cell numbers and do not provide absolute quantification.[1-2] Furthermore, heterogeneity in gene expression and regulation is known to exist within a cell population due to cell-to-cell variation and is often masked when conducting ensemble average measurements. Single cell analysis enables this cellular heterogeneity to be identified and provides a more sensitive method for measuring miRNA levels in scarce, clinical material. It enables the full observation of cellular heterogeneity in cell populations, including the presence of rare cells and ensures that data collected from outlier cells do not bias the data from the cell population.  

Previously our group demonstrated the use of the Microfluidic Antigen Capture (MAC) chip to analyse proteins in mammalian and plant cells.[3] We herein report the development of the MAC chip for single cell miRNA quantification. This is achieved by utilizing a sandwich assay that encompasses capture and reporter oligonucleotide probes complementary to the target miRNA sequence of interest, enabling single cell sensitivity and more precise quantification (Figure 1). We initially optimised the chemical surface functionalisation and concentrations of the capture and reporter probes to achieve a low background signal and high capture efficiency. We demonstrate the robustness of this microfluidic technique in capturing and quantifying miR-21 in mammalian cells and primary airway fibroblasts and epithelial cells obtained from chronic obstructive pulmonary disease (COPD) and healthy patients. This novel technique provides large scale screening of hundreds of specific miRNAs at one time and multiple miRNAs can be simultaneously detected, highlighting a novel biological insight towards human microRNA that reveals rich variation at a single cell level.  

We would like to thank the Institute of Chemical Biology at Imperial College, and the financial support provided by the Engineering and Physical Sciences Research Council.

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info